Skip to main content
Active Biotech logo

Active Biotech — Investor Relations & Filings

Ticker · ACTI ISIN · SE0023261052 LEI · 549300OJ44CLMRU8YE43 ST Professional, scientific and technical activities
Open in API
Filings indexed 832 across all filing types
Latest filing 2026-05-20 Declaration of Voting R…
Country SE Sweden
Listing ST ACTI

About Active Biotech

https://www.activebiotech.com/en/

Active Biotech is a biotechnology company that develops pharmaceuticals for specialist indications with high medical need, focusing on oncology and inflammatory eye disorders. The company leverages its knowledge of the immune system to advance its clinical pipeline. Its portfolio includes fully-owned projects such as tasquinimod for hematological cancers, including multiple myeloma and myelofibrosis, and laquinimod, developed as eye drops for non-infectious uveitis. Additionally, the company has licensed projects, including naptumomab, which is being developed in partnership with NeoTX for the treatment of solid tumors.

Recent filings

Filing Released Lang Actions
Årsstämma i Active Biotech AB
Declaration of Voting Results & Voting Rights Announcements Classification · 72% confidence The document is a press release summarizing the resolutions and decisions taken at the Annual General Meeting held on May 20, 2026. It lists shareholder vote outcomes on dividend, discharge of liability, board elections, reverse share split, amendments to the articles of association, and share issue authorizations. It is not the AGM presentation materials (slides), nor an annual report or interim report. Rather, it is an official declaration of the decisions (voting outcomes) at the AGM, fitting the Declaration of Voting Results category.
2026-05-20 Swedish
Annual General Meeting of Active Biotech AB
Declaration of Voting Results & Voting Rights Announcements Classification · 90% confidence The document is a press release summarizing the resolutions passed at the Annual General Meeting of Active Biotech AB, including dividend decisions, board elections, amendments to articles, share reverse split, and authorization to issue new shares. It reports the outcomes of shareholder votes at the AGM. This fits the definition of a Declaration of Voting Results & Voting Rights Announcements (DVA).
2026-05-20 English
Interim / Quarterly Report 2026
Interim / Quarterly Report
2026-05-07 English
Interim / Quarterly Report 2026
Interim / Quarterly Report
2026-05-07 English
KALLELSE TILL ÅRSSTÄMMA
AGM Information Classification · 100% confidence The document is a detailed notice (kallelse) for the Annual General Meeting (Årsstämma) of Active Biotech AB, scheduled for May 20, 2026. It includes the agenda for the meeting, proposals for board member elections, decisions on share consolidation (reverse split), authorization for share issuance, and other shareholder meeting procedural details. It also references the availability of the annual report and other documents but does not contain the report itself. The content is typical of materials shared to inform shareholders about the AGM and to prepare them for voting and participation. Therefore, this document fits the category of AGM Information (AGM-R).
2026-04-17 Swedish
NOTICE OF ANNUAL GENERAL MEETING
AGM Information Classification · 100% confidence The document is a detailed notice of the Annual General Meeting (AGM) for Active Biotech AB, including the date, location, agenda items, shareholder participation instructions, proposed resolutions, and other procedural information. It does not contain the actual Annual Report or financial statements but refers to their availability. The content focuses on the meeting logistics, agenda, and shareholder voting matters, which aligns with materials typically shared for an AGM. Therefore, this document fits the category of AGM Information (AGM-R). The document length and detail confirm it is not a brief announcement or a proxy solicitation but the full AGM notice.
2026-04-17 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.